NCT03684161

Brief Summary

The overall objective for this study is to evaluate the cardiopulmonary function of VSD-patients compared with healthy age- and gender-matched controls. VSD patients with a surgically corrected defect and VSD patients with a small persistent defect will be included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

September 24, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2019

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

September 10, 2019

Status Verified

September 1, 2018

Enrollment Period

11 months

First QC Date

September 6, 2018

Last Update Submit

September 9, 2019

Conditions

Keywords

Congenital Heart DiseaseVentricular Septal DefectLong-term OutcomeCardiopulmonary Function

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen uptake

    (ml O2/kg/min)

    One week.

Secondary Outcomes (6)

  • Forced expiratory volume in one second (FEV1)

    One week.

  • Peak isovolumetric acceleration during exercise

    One year.

  • Airway resistance

    One week.

  • Diffusion capacity for carbon monoxide

    One week.

  • Health-related quality of life

    Post hoc evaluation. 1 year.

  • +1 more secondary outcomes

Study Arms (3)

Surgically closed VSDs

Patients born with a ventricular septal defect, which have been closed in early childhood.

Diagnostic Test: Cardiopulmonary function

Small, persistent VSDs

Patients born with a small, hemodynamically insignificant ventricular septal defect.

Diagnostic Test: Cardiopulmonary function

Healthy controls

Healthy control subjects.

Diagnostic Test: Cardiopulmonary function

Interventions

Body composition measurements; Pulmonary function tests; Cardiopulmonary exercise test; Force frequency releationship, ultrasound

Healthy controlsSmall, persistent VSDsSurgically closed VSDs

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of three groups; a group of small unrepaired VSDs, a group of surgically corrected VSDs and a group of healthy, age-matched controls. Each group is aimed at including 20 participants.

You may qualify if:

  • Patients born between 1938 and 1978.
  • Patients registered with DX Q21.0, and if the defect is unrepaired in accordance with criteria from the ESC guidelines 5 or is repaired as documented by the procedural code KFHB.
  • Recruitment of healthy control subjects will take place by means of adverts at the website www.forsoegspersoner.dk. Control subjects will be matched by likewise age-groups.

You may not qualify if:

  • Lack of medical record
  • Serious congenital cardiac abnormalities
  • Lack of Danish language skills
  • Severe lung or heart disease
  • Syndromes, such as Down's
  • Mentally or physically incompetent to perform the tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiothoracic and Vascular Surgery

Aarhus C, 8000, Denmark

Location

Related Publications (32)

  • Larsen SH, Olsen M, Emmertsen K, Hjortdal VE. Interventional Treatment of Patients With Congenital Heart Disease: Nationwide Danish Experience Over 39 Years. J Am Coll Cardiol. 2017 Jun 6;69(22):2725-2732. doi: 10.1016/j.jacc.2017.03.587.

    PMID: 28571637BACKGROUND
  • Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001 Apr;37(5):1170-5. doi: 10.1016/s0735-1097(01)01272-4. No abstract available.

    PMID: 11300418BACKGROUND
  • Webb GD. Care of adults with congenital heart disease--a challenge for the new millennium. Thorac Cardiovasc Surg. 2001 Feb;49(1):30-4. doi: 10.1055/s-2001-9918.

    PMID: 11243519BACKGROUND
  • Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008 Dec 2;118(23):e714-833. doi: 10.1161/CIRCULATIONAHA.108.190690. Epub 2008 Nov 7. No abstract available.

    PMID: 18997169BACKGROUND
  • Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57. doi: 10.1093/eurheartj/ehq249. Epub 2010 Aug 27. No abstract available.

    PMID: 20801927BACKGROUND
  • Onat T, Ahunbay G, Batmaz G, Celebi A. The natural course of isolated ventricular septal defect during adolescence. Pediatr Cardiol. 1998 May-Jun;19(3):230-4. doi: 10.1007/s002469900291.

    PMID: 9568219BACKGROUND
  • Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J. 1998 Oct;19(10):1573-82. doi: 10.1053/euhj.1998.1083.

    PMID: 9820997BACKGROUND
  • Heiberg J, Schmidt MR, Redington A, Hjortdal VE. Disrupted right ventricular force-frequency relationships in adults operated for ventricular septal defect as toddlers: abnormal peak force predicts peak oxygen uptake during exercise. Int J Cardiol. 2014 Dec 20;177(3):918-24. doi: 10.1016/j.ijcard.2014.10.009. Epub 2014 Oct 28.

    PMID: 25456699BACKGROUND
  • Heiberg J, Laustsen S, Petersen AK, Hjortdal VE. Reduced long-term exercise capacity in young adults operated for ventricular septal defect. Cardiol Young. 2015 Feb;25(2):281-7. doi: 10.1017/S1047951113002084. Epub 2013 Nov 21.

    PMID: 24565413BACKGROUND
  • Maagaard M, Heiberg J, Hjortdal VE. Small, unrepaired ventricular septal defects reveal poor exercise capacity compared with healthy peers: A prospective, cohort study. Int J Cardiol. 2017 Jan 15;227:631-634. doi: 10.1016/j.ijcard.2016.10.086. Epub 2016 Oct 29.

    PMID: 27810297BACKGROUND
  • Maagaard M, Heiberg J, Asschenfeldt B, Ringgaard S, Hjortdal VE. Does functional capacity depend on the size of the shunt? A prospective, cohort study of adults with small, unrepaired ventricular septal defects. Eur J Cardiothorac Surg. 2017 Apr 1;51(4):722-727. doi: 10.1093/ejcts/ezw420.

    PMID: 28204298BACKGROUND
  • Heiberg J, Petersen AK, Laustsen S, Hjortdal VE. Abnormal ventilatory response to exercise in young adults operated for ventricular septal defect in early childhood: A long-term follow-up. Int J Cardiol. 2015 Sep 1;194:2-6. doi: 10.1016/j.ijcard.2015.05.071. Epub 2015 May 15.

    PMID: 26011258BACKGROUND
  • Rex CE, Eckerstrom F, Heiberg J, Maagaard M, Rubak S, Redington A, Hjortdal VE. Surgical closure of a ventricular septal defect in early childhood leads to altered pulmonary function in adulthood: A long-term follow-up. Int J Cardiol. 2019 Jan 1;274:100-105. doi: 10.1016/j.ijcard.2018.06.109. Epub 2018 Jul 2.

    PMID: 30001944BACKGROUND
  • Gabriels C, De Backer J, Pasquet A, Paelinck BP, Morissens M, Helsen F, Van De Bruaene A, Budts W. Long-Term Outcome of Patients with Perimembranous Ventricular Septal Defect: Results from the Belgian Registry on Adult Congenital Heart Disease. Cardiology. 2017;136(3):147-155. doi: 10.1159/000448513. Epub 2016 Sep 21.

    PMID: 27648950BACKGROUND
  • Asschenfeldt B, Heiberg J, Ringgaard S, Maagaard M, Redington A, Hjortdal VE. Impaired cardiac output during exercise in adults operated for ventricular septal defect in childhood: a hitherto unrecognised pathophysiological response. Cardiol Young. 2017 Oct;27(8):1591-1598. doi: 10.1017/S1047951117000877. Epub 2017 May 25.

    PMID: 28539128BACKGROUND
  • Karonis T, Scognamiglio G, Babu-Narayan SV, Montanaro C, Uebing A, Diller GP, Alonso-Gonzalez R, Swan L, Dimopoulos K, Gatzoulis MA, Li W. Clinical course and potential complications of small ventricular septal defects in adulthood: Late development of left ventricular dysfunction justifies lifelong care. Int J Cardiol. 2016 Apr 1;208:102-6. doi: 10.1016/j.ijcard.2016.01.208. Epub 2016 Jan 23.

    PMID: 26844920BACKGROUND
  • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.

    PMID: 18839484BACKGROUND
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

    PMID: 16055882BACKGROUND
  • DUBOIS AB, BOTELHO SY, BEDELL GN, MARSHALL R, COMROE JH Jr. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956 Mar;35(3):322-6. doi: 10.1172/JCI103281. No abstract available.

    PMID: 13295396BACKGROUND
  • Horsley A. Lung clearance index in the assessment of airways disease. Respir Med. 2009 Jun;103(6):793-9. doi: 10.1016/j.rmed.2009.01.025. Epub 2009 Feb 25.

    PMID: 19246184BACKGROUND
  • Horsley AR, Gustafsson PM, Macleod KA, Saunders C, Greening AP, Porteous DJ, Davies JC, Cunningham S, Alton EW, Innes JA. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax. 2008 Feb;63(2):135-40. doi: 10.1136/thx.2007.082628. Epub 2007 Aug 3.

    PMID: 17675315BACKGROUND
  • Verbanck S, Thompson BR, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, Van Muylem A, Paiva M, Vincken W, Usmani O. Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax. 2012 Sep;67(9):789-95. doi: 10.1136/thoraxjnl-2011-201484. Epub 2012 Apr 27.

    PMID: 22544894BACKGROUND
  • Johnson DC. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med. 2000 Jan;94(1):28-37. doi: 10.1053/rmed.1999.0740.

    PMID: 10714476BACKGROUND
  • Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012 Mar;129(3):671-8. doi: 10.1016/j.jaci.2011.11.002. Epub 2011 Dec 17.

    PMID: 22178635BACKGROUND
  • Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F; ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003 Dec;22(6):1026-41. doi: 10.1183/09031936.03.00089403.

    PMID: 14680096BACKGROUND
  • Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol (1985). 1986 Jun;60(6):2020-7. doi: 10.1152/jappl.1986.60.6.2020.

    PMID: 3087938BACKGROUND
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.

    PMID: 12900694BACKGROUND
  • Selskab DC. Anbefalinger for standardiseret minimumskrav til transthorakal ekkokardiografi hos voksne. In: Selskab DC, ed. Dansk Cardiologisk Selskab DCS: DCS, 2008.

    BACKGROUND
  • Brun H, Moller T, Fredriksen PM, Thaulow E, Pripp AH, Holmstrom H. Mechanisms of exercise-induced pulmonary hypertension in patients with cardiac septal defects. Pediatr Cardiol. 2012 Jun;33(5):782-90. doi: 10.1007/s00246-012-0216-9. Epub 2012 Mar 1.

    PMID: 22383098BACKGROUND
  • Cheung MM, Smallhorn JF, McCrindle BW, Van Arsdell GS, Redington AN. Non-invasive assessment of ventricular force-frequency relations in the univentricular circulation by tissue Doppler echocardiography: a novel method of assessing myocardial performance in congenital heart disease. Heart. 2005 Oct;91(10):1338-42. doi: 10.1136/hrt.2004.048207.

    PMID: 16162630BACKGROUND
  • Maagaard M, Eckerstrom F, Schram AL, Jensen HAR, Hjortdal V. Health and Well-Being in Older Adults With a Surgically Closed or an Unrepaired Ventricular Septal Defect. J Am Heart Assoc. 2023 Aug 15;12(16):e028538. doi: 10.1161/JAHA.122.028538. Epub 2023 Aug 7.

  • Eckerstrom F, Maagaard M, Boutrup N, Hjortdal VE. Pulmonary Function in Older Patients With Ventricular Septal Defect. Am J Cardiol. 2020 Jun 1;125(11):1710-1717. doi: 10.1016/j.amjcard.2020.02.014. Epub 2020 Mar 13.

MeSH Terms

Conditions

Heart Septal Defects, VentricularHeart Defects, Congenital

Condition Hierarchy (Ancestors)

Heart Septal DefectsCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Vibeke E Hjortdal, MD, PhD, DMSc

    Dept. of Cardiothoracic and Vascular Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2018

First Posted

September 25, 2018

Study Start

September 24, 2018

Primary Completion

August 12, 2019

Study Completion

September 1, 2019

Last Updated

September 10, 2019

Record last verified: 2018-09

Locations